Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee

Conclusions
It is crucial to perform paediatric trials early in the development of new drugs in order to reduce off-label use of IBD medication in children. The thoughtful choice of feasible and standardised outcome measures can help move us towards this goal.

Source: Gut - February 3, 2015 Category: Gastroenterology Authors: Ruemmele, F. M., Hyams, J. S., Otley, A., Griffiths, A., Kolho, K.-L., Dias, J. A., Levine, A., Escher, J. C., Taminiau, J., Veres, G., Colombel, J.-F., Vermeire, S., Wilson, D. C., Turner, D. Tags: Crohn's disease, Ulcerative colitis Inflammatory bowel disease Source Type: research